218 related articles for article (PubMed ID: 23386644)
1. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
Villanueva JA; Sokalska A; Cress AB; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ
J Clin Endocrinol Metab; 2013 Mar; 98(3):E455-62. PubMed ID: 23386644
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis.
Ortega I; Villanueva JA; Wong DH; Cress AB; Sokalska A; Stanley SD; Duleba AJ
J Ovarian Res; 2014 Feb; 7():21. PubMed ID: 24524197
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin decreases invasiveness of human endometrial stromal cells.
Sokalska A; Cress A; Bruner-Tran KL; Osteen KG; Taylor HS; Ortega I; Duleba AJ
Biol Reprod; 2012 Jul; 87(1):2, 1-6. PubMed ID: 22492974
[TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis.
Sokalska A; Anderson M; Villanueva J; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ
J Clin Endocrinol Metab; 2013 Mar; 98(3):E463-71. PubMed ID: 23337719
[TBL] [Abstract][Full Text] [Related]
6. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
7. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Parker RA; Pearce BC; Clark RW; Gordon DA; Wright JJ
J Biol Chem; 1993 May; 268(15):11230-8. PubMed ID: 8388388
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells.
Sokalska A; Wong DH; Cress A; Piotrowski PC; Rzepczynska I; Villanueva J; Duleba AJ
J Clin Endocrinol Metab; 2010 Jul; 95(7):3453-9. PubMed ID: 20427495
[TBL] [Abstract][Full Text] [Related]
9. Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability.
Piotrowski PC; Kwintkiewicz J; Rzepczynska IJ; Seval Y; Cakmak H; Arici A; Duleba AJ
Biol Reprod; 2006 Jul; 75(1):107-11. PubMed ID: 16571871
[TBL] [Abstract][Full Text] [Related]
10. Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis.
Loregger A; Raaben M; Tan J; Scheij S; Moeton M; van den Berg M; Gelberg-Etel H; Stickel E; Roitelman J; Brummelkamp T; Zelcer N
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2064-2074. PubMed ID: 28882874
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?
Li H; Lewis A; Brodsky S; Rieger R; Iden C; Goligorsky MS
Circulation; 2002 Mar; 105(9):1037-43. PubMed ID: 11877351
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
13. The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.
Bhardwaj A; Singh H; Trinidad CM; Albarracin CT; Hunt KK; Bedrosian I
Breast Cancer Res; 2018 Dec; 20(1):150. PubMed ID: 30537987
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin on castration-resistant prostate cancer cells.
Kim JH; Cox ME; Wasan KM
Lipids Health Dis; 2014 Mar; 13():56. PubMed ID: 24666612
[TBL] [Abstract][Full Text] [Related]
15. Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition.
Aboushadi N; Shackelford JE; Jessani N; Gentile A; Krisans SK
Biochemistry; 2000 Jan; 39(1):237-47. PubMed ID: 10625499
[TBL] [Abstract][Full Text] [Related]
16. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin.
Medina MW; Gao F; Ruan W; Rotter JI; Krauss RM
Circulation; 2008 Jul; 118(4):355-62. PubMed ID: 18559695
[TBL] [Abstract][Full Text] [Related]
18. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
Hidaka Y; Hotta H; Nagata Y; Iwasawa Y; Horie M; Kamei T
J Biol Chem; 1991 Jul; 266(20):13171-7. PubMed ID: 1649182
[TBL] [Abstract][Full Text] [Related]
19. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
